BindingDB logo
myBDB logout

8 articles for BASF AG

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
11992781 Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonists. 06-MAY-2002 19-MAY-2013
18068982 Design and synthesis of novel potent and selective integrin alphanubeta3 antagonists--novel synthetic routes to isoquinolinone, benzoxazinone, and quinazolinone acetates. 21-JAN-2008 15-DEC-2012
12781189 D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety. 03-JUN-2003 07-OCT-2012
12039564 Solid-phase synthesis of thrombin inhibitors. 31-MAY-2002 05-OCT-2012
8667356 Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. 02-AUG-1996 10-NOV-2009
12729650 Solid-phase synthesis of endothelin receptor antagonists. 05-MAY-2003 10-NOV-2009
10447946 Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist. 02-SEP-1999 10-NOV-2009
12482416 Highly potent and selective alphaVbeta3-receptor antagonists: solid-phase synthesis and SAR of 1-substituted 4-amino-1H-pyrimidin-2-ones. 16-DEC-2002 10-NOV-2009